Publication: The Value of Pharmacovigilance in Building Resilient Health Systems Post-COVID: Overview Report
Loading...
Date
2023-08-15
ISSN
Published
2023-08-15
Editor(s)
Abstract
Although indispensable for improving health outcomes, medicines and vaccines or their administration and use can produce adverse effects, requiring continuous vigilance to ensure that the benefits outweigh the risks. Monitoring the safety of the use of marketed medicines and vaccines, also known as pharmacovigilance, should therefore become much more explicit in efforts to strengthen health systems and prepare for public health crises and normal times because the world is determined to build back better after the COVID-19 pandemic. The objective of this report is to examine the importance of pharmacovigilance in a health system both during a health crisis and in normal times, describe the function, structure, and processes of a functional pharmacovigilance system, and explain the value of drug safety monitoring in building resilience in health systems post-COVID-19 pandemic.
Link to Data Set
Citation
“Wang,Huihui; Marquez,Patricio V.; Figueras Sune,Albert-Jesus; Kseniya Bieliaieva. 2023. The Value of Pharmacovigilance in Building Resilient Health Systems Post-COVID: Overview Report. Pharmacovigilance and Essential Public Health Services Series. © World Bank. http://hdl.handle.net/10986/40205 License: CC BY-NC 3.0 IGO.”
Associated URLs
Associated content
Other publications in this report series
Journal
Journal Volume
Journal Issue
Collections
Related items
Showing items related by metadata.
Error: Could not load results for 'https://openknowledge.worldbank.org/server/api/item/relateditemlistconfigs/a9f3c344-08d3-465b-8d33-09c592f34934_metadata/itemlist'.
Users also downloaded
Showing related downloaded files
Error: Could not load results for 'https://openknowledge.worldbank.org/server/api/item/relateditemlistconfigs/a9f3c344-08d3-465b-8d33-09c592f34934_downloads/itemlist'.